Anavex Life Sciences Corp (AVXL)

[attilathehunt]

"But I am starting to think shorting biotechs with market caps under $2B should be illegal, and instead the SEC ought to step up enforcement of these companies to make sure they aren't misleading investors."

It should be based on revenue (i.e.)...no shorting on companies with less $10B in revenues.